Paris, 14 February 2013– NYSE Euronext (NYX) today announced the listing on NYSE Alternext in Paris of Spineway, a company specialised in surgical implants and instruments used to treat spinal column pathologies.
Founded in 2005, Spineway designs, manufactures and markets leading-edge surgical instruments and implants that make spinal surgery more effective. Based in the Lyon suburb of Bron, the company has a distribution network of 48 specialists serving markets outside France. With nearly 30 employees, Spineway has harnessed its founders’ 15 years of experience to build a worldwide reputation for expertise and technical excellence in its field.
Spineway (ticker: ALSPW) was listed through admission to trading of 2,800,500 existing shares and 595,003 new shares issued as a private placement with qualified investors. The private placement raised a total of €4.9 million.
The admission and issue price of Spineway was set at €7.47 per share. Market capitalisation stood at around €25.4 million on the day of listing.
“We are delighted to welcome Spineway to NYSE Alternext, our organized market dedicated to small and mid-size companies - a market with regulations matched to the needs of medtech companies,” said Marc Lefèvre, Head of European Business Development and Client Coverage, Listings Europe, at NYSE Euronext. “Spineway has won worldwide recognition as an expert in spinal column surgery. Today it is raising the capital it needs to grow by listing, which will boost its profile and appeal for investors.”
Spineway Chairman and CEO Stéphane Le Roux added, “We are very happy with Spineway’s stockmarket listing and the success of this first transaction. This important step that will enable us to step up the pace of growth significantly while maintaining the independence we have always with Philippe Laurito - ever since Spineway was founded. We want to thank all of the investors who have taken part for their interest and their trust.”
In seven years, €2.7 billion has been raised on NYSE Alternext, half through secondary issues, by companies from countries including Belgium, Canada, China, France, Italy, Luxembourg, the Netherlands, Spain, the UK and the US. Their marketcapitalisation totals over €6 billion. Today 180 companies are listed on NYSE Alternext.